Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scot C Remick

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Cancer Investigation|April 9, 2004
Surrogate markers in oncology practice and anticancer drug development: lessons learned from antiretroviral therapy?Scot C Remick
Future Oncology (London, England)|August 31, 2010
Combretastatin A4 phosphate: a novel vascular disrupting agentGovardhanan Nagaiah, Scot C Remick
Current Opinion in Oncology|August 9, 2006
Challenges and opportunities for treatment and research of AIDS-related malignancies in AfricaJackson Orem, Mwanda W Otieno, Scot C Remick
Current Opinion in Oncology|August 18, 2004
AIDS-associated cancer in developing nationsJackson Orem, Mwanda W Otieno, Scot C Remick
Plos One|March 3, 2011
Combining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based studyJoseph Putila, Scot C Remick, Nancy Lan Guo
Journal of Oncology Practice|September 3, 2011
Barriers to recruitment of rural patients in cancer clinical trialsShamsuddin Virani, Lola Burke, Scot C Remick, et al.
Current Treatment Options in Oncology|August 19, 2005
Promising systemic therapy for renal cell carcinomaMatthew M Cooney, Scot C Remick, Nicholas J Vogelzang
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Novel agents for the treatment of advanced kidney cancerMatthew M Cooney, Scot C Remick, Nicholas J Vogelzang
Current Urology Reports|January 22, 2004
A medical oncologist's approach to immunotherapy for advanced renal tumors: is nephrectomy indicated?Matthew M Cooney, Scot C Remick, Nicholas J Vogelzang
Journal of Women'S Health (2002)|March 23, 2011
Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service programRahul Khanna, S Suresh Madhavan, Abhijeet Bhanegaonkar, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Cancer Investigation|April 9, 2004
Surrogate markers in oncology practice and anticancer drug development: lessons learned from antiretroviral therapy?Scot C Remick
Future Oncology (London, England)|August 31, 2010
Combretastatin A4 phosphate: a novel vascular disrupting agentGovardhanan Nagaiah, Scot C Remick
Current Opinion in Oncology|August 9, 2006
Challenges and opportunities for treatment and research of AIDS-related malignancies in AfricaJackson Orem, Mwanda W Otieno, Scot C Remick
Current Opinion in Oncology|August 18, 2004
AIDS-associated cancer in developing nationsJackson Orem, Mwanda W Otieno, Scot C Remick
Plos One|March 3, 2011
Combining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based studyJoseph Putila, Scot C Remick, Nancy Lan Guo
Journal of Oncology Practice|September 3, 2011
Barriers to recruitment of rural patients in cancer clinical trialsShamsuddin Virani, Lola Burke, Scot C Remick, et al.
Current Treatment Options in Oncology|August 19, 2005
Promising systemic therapy for renal cell carcinomaMatthew M Cooney, Scot C Remick, Nicholas J Vogelzang
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Novel agents for the treatment of advanced kidney cancerMatthew M Cooney, Scot C Remick, Nicholas J Vogelzang
Current Urology Reports|January 22, 2004
A medical oncologist's approach to immunotherapy for advanced renal tumors: is nephrectomy indicated?Matthew M Cooney, Scot C Remick, Nicholas J Vogelzang
Journal of Women'S Health (2002)|March 23, 2011
Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service programRahul Khanna, S Suresh Madhavan, Abhijeet Bhanegaonkar, et al.
Pageof 10